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Mice lacking the mitochondrial exonuclease
MGME1 accumulate mtDNA deletions without
developing progeria
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Replication of mammalian mitochondrial DNA (mtDNA) is an essential process that requires
high fidelity and control at multiple levels to ensure proper mitochondrial function. Mutations
in the mitochondrial genome maintenance exonuclease 1 (MGME1) gene were recently
reported in mitochondrial disease patients. Here, to study disease pathophysiology, we
generated Mgme1 knockout mice and report that homozygous knockouts develop depletion
and multiple deletions of mtDNA. The mtDNA replication stalling phenotypes vary drama-
tically in different tissues of Mgme1 knockout mice. Mice with MGME1 deficiency accumulate
a long linear subgenomic mtDNA species, similar to the one found in mtDNA mutator mice,
but do not develop progeria. This finding resolves a long-standing debate by showing that
point mutations of mtDNA are the main cause of progeria in mtDNA mutator mice. We also
propose a role for MGME1 in the regulation of replication and transcription termination at the
end of the control region of mtDNA.
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M itochondrial diseases represent the most commongroup of inherited metabolic diseases in humans with aprevalence of about 1 in 50001. These genetically het-
erogeneous disorders can be caused by mutations in mitochon-
drial DNA (mtDNA) or in nuclear genes that encode proteins
with mitochondrial function2. Mutations in nuclear genes cause
mtDNA instability resulting in mtDNA depletion or accumula-
tion of deletions and/or point mutations, ultimately leading to
impaired oxidative phosphorylation (OXPHOS). The vast
majority of mutations causing human mtDNA instability map to
genes encoding proteins involved in mtDNA replication, e.g., the
catalytic subunit of mtDNA polymerase (POLGA)3, the accessory
subunit of mtDNA polymerase (POLGB)4, the replicative helicase
(TWNK)5, DNA replication helicase/nuclease 2 (DNA2)6, mito-
chondrial genome maintenance exonuclease 1 (MGME1)7 and
ribonuclease H1 (RNASEH1)8, or nucleotide pool regulation, e.g.,
thymidine phosphorylase (TP)9, mitochondrial thymidine kinase
(TK2)10, deoxyguanosine kinase (DGUOK)11, ATP-dependent
succinate-CoA ligase (SUCLA2)12, and GTP-dependent succi-
nate-CoA ligase (SUCLG1)1,13,14. Mitochondrial disorders are
highly variable in disease severity and clinical presentation, and
display tissue-specific manifestations. The basis for the clinical
heterogeneity and tissue specificity of mutations in these ubi-
quitously expressed genes is unknown. The fact that mtDNA
maintenance defects primarily involve high energy demanding
tissues, such as brain and muscle, can only partially explain the
tissue specificity seen in mitochondrial disorders. Other organs
are also frequently affected causing, e.g., cardiomyopathy, dia-
betes mellitus, liver dysfunction, and optic neuropathy1. Extensive
in vitro work has led to significant progress in our understanding
of the biochemical processes underlying mtDNA maintenance
disorders4,15,16, but animal models are nevertheless essential to
understand the wide range of phenotypes and secondary meta-
bolic consequences of mtDNA instability in different tissues17.
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Fig. 1 Conditional knockout of Mgme1. a Targeting strategy for disruption of the Mgme1 gene. Magenta arrows loxP sequences; turquoise arrows FRT sites.
b Schematic representation of Mgme1 cDNA. RT-PCR analysis of Mgme1 transcripts from control (+/+) and Mgme1 knockout mice (−/−). cWestern blot
analysis of MGME1 levels in heart, liver, kidney, and spleen mitochondrial extracts of Mgme1 knockout (−/−) and wild-type (+/+) mice and heart
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Various animal models have increased our understanding of
progression and disease mechanisms in mtDNA maintenance
disorders and this will eventually open new avenues for ther-
apeutic intervention3,10,18–21.
To gain further insight into diseases of defective mtDNA
replication, we created a knockout mouse model for the recently
described disease gene encoding MGME1 (also known as Ddk1)7,22.
Loss-of-function mutations in MGME1 were reported to cause a
severe multisystem mitochondrial disorder in humans with
depletion and rearrangements of mtDNA7,23. Patients with loss-
of-function MGME1 mutations have progressive external oph-
thalmoplegia, skeletal muscle wasting/weakness, emaciation,
respiratory distress, severe dilated cardiomyopathy, micro-
cephalus, mental retardation, and severe gastrointestinal symp-
toms. Biochemically, MGME1 is a single-stranded DNA nuclease
involved in processing of 5′ mtDNA ends generated during
replication7,22,24. Loss of MGME1 expression, either in siRNA
treated cells or in patient fibroblasts, leads to an accumulation of
7S DNA7,23, which is the single-stranded DNA species formed by
premature replication termination at the end of the control region
of mtDNA23, thus suggesting a role for MGME1 in repressing
formation or increasing turnover of these molecules.
We have studied the in vivo mtDNA replication phenotypes
associated with MGME1 deficiency in various mouse tissues of
knockout mice. Although MGME1 is not essential for embryonic
development, its loss leads to accumulation of multiple deletions
and depletion of mtDNA in a range of different mouse tissues.
Furthermore, our data show that MGME1 is involved in
regulation of heavy-strand replication and transcription termi-
nation. Remarkably, we report that MGME1 knockout mice
display tissue-specific replication stalling patterns, with different
tissues accumulating distinct replication intermediates, showing
that this mouse model is a valuable tool to investigate tissue-
specific pathology caused by the absence of MGME1.
Results
Generation of Mgme1 knockout mice. To study the in vivo
function of theMgme1 gene, we generated a conditional knockout
allele (Fig. 1a). The mutated locus (Mgme1+/loxP-pur) was trans-
mitted through the mouse germline and the puromycin selection
cassette was removed by mating with transgenic mice ubiqui-
tously expressing the Flp-recombinase. Mice heterozygous for the
loxP-flanked Mgme1 allele (Mgme1+/loxP) were mated to mice
ubiquitously expressing cre-recombinase (β-actin-cre) to obtain
heterozygous Mgme1 knockout (Mgme1+/−) mice. An intercross
of heterozygous Mgme1+/− animals gave viable homozygous
knockout Mgme1−/− pups at the approximate expected Mende-
lian ratios (genotyped pups n= 204;Mgme1−/− n= 36;Mgme1+/−
n= 119; Mgme1+/+; n= 49). Mgme1−/− mice had a normal
gross appearance and were followed until the age of 70 weeks
(Supplementary Fig. 1). Reverse transcription (RT)-PCR analyses
of the Mgme1 mRNA confirmed the absence of sequences cor-
responding to exon 3 (Fig. 1b) and the MGME1 protein was
absent on western blots (Fig. 1c) in all investigated tissues of
Mgme1−/−mice. We also generated heart- and skeletal-muscle-
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Fig. 2 MtDNA depletion and accumulation of deletions in Mgme1 homozygous and tissue-specific knockout mice in various tissues. a Long-extension PCR
of heart-isolated total DNA from 8 weeks old controls (+/+) and Mgme1 knockout mice (−/−) using primers amplifying major arc. # indicates product
form full-length mtDNA, parentheses indicate deleted products. The bands are visualized by EtBr staining. b Southern blot analysis of SacI-digested heart
mtDNA from control (Mgme1L/L) and tissue-specific knockout mice (Mgme1L/L, cre), wild-type (Mgme1+/+) and Mgme1 knockout mice (Mgme1−/−) and
control (PolgA+/+) and mtDNA-mutator mice (PolgAmut/mut). Plasmid pAM1, containing whole mtDNA sequence was used as a probe. # full-length
mtDNA; *deleted mtDNA molecules. c Southern blot quantification: ratio of full-length mtDNA signal to 18S loading control. Error bars represent the SEM.
**P < 0,001, Statistical analysis were performed using Student’s t-test. n= 3 biological replicates. d Southern blot analysis of SacI-digested mtDNA from
brain, skeletal muscle, kidney, and liver tissue. (+/+), control; (−/−), Mgme1 knockout mice. Plasmid containing whole mtDNA sequence was used as a
probe. # full-length mtDNA; *deleted mtDNA fragments
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03552-x ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1202 | DOI: 10.1038/s41467-018-03552-x | www.nature.com/naturecommunications 3
specific Mgme1 knockout mice (Mgme1loxP/loxP; +/Ckmm-cre)
that had no obvious phenotype when followed until 12 months of
age. The MGME1 protein was absent in heart of theMgme1loxP/loxP;
+/Ckmm-cre animals (Fig. 1c). These results show that mice with
both germline and tissue-specific knockout of Mgme1 are viable
and appear healthy.
Widespread distribution of deleted mtDNA in Mgme1−/−
mice. We performed long-extension PCR on total heart DNA to
assess mtDNA integrity in Mgme1−/− mice (Fig. 2a). When we
used a primer pair (Supplementary Fig. 2a) designed to amplify
the major arc of mtDNA, which is the region most commonly
affected by deletions, we found multiple shorter molecules on
long-extension PCR, consistent with the presence of mtDNA
rearrangements in Mgme1−/− mice (Fig. 2a). Moreover, Southern
blot analyses of heart DNA from Mgme1loxP/loxP; +/Ckmm-cre
mice and various tissues of Mgme1−/− mice showed both
mtDNA depletion and a prominent deletion of mtDNA
(Fig. 2b–d). With restriction enzyme mapping, we established
that the deleted species was a linear mtDNA molecule of ~11 kb
that lacks sequences corresponding to the minor arc of mtDNA,
which is the shorter region extending between the origin of
replication of the leading (heavy, OH) and lagging (light, OL)
strand of mtDNA. Consistent with the location of the deletion,
both SacI (Fig. 2b, d and Supplementary Fig. 2d) and XhoI
(Supplementary Fig. 2b) digested the linear mtDNA species into
two fragments. In contrast, EagI, which only digests mtDNA in
the minor arc region, did not cut the linear mtDNA molecule
(Supplementary Fig. 2c). Similar to the findings inMgme1−/−mice,
patients with pathogenic MGME1 mutations display multiple
mtDNA deletions in skeletal muscle, blood and urine on long-
extension PCR analyses7, as well as mtDNA depletion and high
levels of a linear subgenomic mtDNA molecule on Southern blot
analyses of fibroblast mtDNA7,23. We have previously reported
that the prematurely ageing mtDNA mutator (PolgAmut/mut)
mouse has high levels of a linear subgenomic mtDNA molecule in
addition to high levels of point mutations in mtDNA25,26. The
linear subgenomic mtDNA molecules are very similar in size
(Fig. 2b, Supplementary Fig. 2b, d) in Mgme1−/− and PolgAmut/
mut mice. However, Mgme1−/− mice accumulate more than
double the amount of the 11 kb subgenomic fragment in com-
parison with PolgAmut/mut mice (Supplementary Fig. 2d, e). The
finding of linear subgenomic mtDNA molecules of a similar size
and extension in patients and mice lacking functional MGME1
and in mtDNA mutator mice expressing mutant POLGA suggests
that both enzymes function in the same pathway and that there is
a common mechanism for the formation of those subgenomic
fragments27.
Mgme1 knockout mice do not age prematurely. We assessed the
mtDNA point mutation load in Mgme1−/− mice by using a high-
fidelity polymerase to amplify mtDNA fragments followed by
cloning and sequencing of individual clones. We detected wild-
type levels of point mutations in liver of young (11 weeks of age)
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Fig. 3 Mgme1−/− male mice are fertile and show normal testes morphology. a Pups per litter (data from 7 different males). b Relative testis weight.
c Relative sperm count. d Sperm motility. e Testis seminiferous tubule structure. Scale bar, 100 µm. Data represent mean ± SEM. Statistical analyses were
performed using Student’s t-test. n= 3 biological replicates
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03552-x
4 NATURE COMMUNICATIONS |  (2018) 9:1202 | DOI: 10.1038/s41467-018-03552-x | www.nature.com/naturecommunications
and old Mgme1−/− mice (70 weeks of age) (Supplementary Fig.
3a). Furthermore, we could not detect any significant changes in
the load of mtDNA point mutations in spleen and skeletal muscle
of 70 weeks old Mgme1−/− mice (Supplementary Fig. 3b). The
increase in the point mutation load in mtDNA mutator mice is
associated with premature onset of ageing-related phenotypes,
such as decreased life span, male infertility and anemia25,28,29. In
contrast, Mgme1−/− male mice are fertile with normal testis
weight, normal sperm count, normal sperm motility and unal-
tered testis morphology (Fig. 3a–e).
At 20 weeks of age, Mgme1−/− mice have normal blood
hemoglobin concentration, whereas older animals show a mild
decrease in hemoglobin at the age of 70 weeks (Supplementary
Fig. 4a, b). Importantly, the anemia of Mgme1−/− mice is much
milder than the anemia in mtDNA mutator mice despite the
observation that Mgme1−/− mice have much higher levels of
subgenomic deleted mtDNA than mtDNA mutator mice30. At
the age of 70 weeks Mgme1−/− mice have moderate anemia
without reticulocytosis accompanied by moderate splenomegaly
(Supplementary Fig. 4b–d), whereas mtDNA mutator mice at
40 weeks of age have profound anemia, marked reticulocytosis
and massive splenomegaly with extramedullary
hematopoiesis25,28.
Finally, we performed combined cytochrome c oxidase/
succinate dehydrogenase (COX/SDH) enzyme histochemistry of
heart, colon and skeletal muscle of Mgme1−/− mice and controls
at the ages of 45 and 70 weeks. We found COX deficient cells in
heart and colon from the age of 45 weeks in Mgme1−/− mice,
whereas there were no changes in skeletal muscle (Fig. 4).
Increased stability of 7S DNA in the absence of MGME1. Given
the observed effects on mtDNA quantity and integrity in both
patients and mice lacking MGME1, we investigated regulation of
replication in the control region. Typically, most mtDNA repli-
cation events initiated at the OH region are abortive due to pre-
mature termination at the end of the control region, which results
in the formation of a ~650 nt long nascent DNA species (7S
DNA) that creates a characteristic triple-stranded DNA structure,
the displacement loop (D loop)31. Although the smear around 7S
DNA in Mgme1−/− mice samples prevented us from accurate
quantification of the 7S DNA band, Southern blot analyses sug-
gested an increase of steady-state levels of 7S DNA in Mgme1−/−
mice (Fig. 5a, b). To further investigate the mechanism behind
the altered levels of 7S DNA levels, we performed in organello
mtDNA replication experiments (Fig. 5c)32,33. Freshly isolated
mitochondria from heart tissue were pulse labeled for 2 h with
32P-dATP followed by a one-hour chase to follow the synthesis
and stability of de novo synthesized mtDNA (Fig. 5c). Surpris-
ingly, no de novo synthesis of a distinct 7S DNA species was
found in heart mitochondria from Mgme1−/− mice (Fig. 5c, lanes
2 and 6). However, we observed robust ongoing mtDNA synth-
esis as there was labeling of full-length mtDNA and a smear of
shorter mtDNA species in Mgme1−/− mitochondria, similar to
the findings in wild-type mitochondria (Fig. 5c). The replicative
DNA helicase TWINKLE is essential for mtDNA replication34,
and we, therefore, also analyzed Twnk knockout (TwnkloxP/loxP;
+/Ckmm-cre) heart mitochondria to ensure that the observed
labeling is due to de novo mtDNA synthesis. As expected, no de
novo mtDNA replication products were detected in Twnk
knockout mitochondria (Fig. 5c, lanes 10 and 11).
Moreover, we performed chase experiments and found that 7S
DNA is less stable than full-length mtDNA in wild-type mitochon-
dria (Fig. 5c, lanes 1, 5, and 9 vs lanes 4, 8, and 12), consistent with
previous observations in cultured cells35. To investigate the puzzling
discrepancy between the low de novo synthesis and the high steady-
state levels of 7S DNA in Mgme1−/−mice, we followed the stability
of mtDNA with Southern blot analyses after inhibiting mtDNA
replication with the chain-terminating nucleotide analog 2′,3′-
dideoxycytidine (ddC) in mouse embryonic fibroblasts (MEFs).
In the presence of ddC no 7S DNA is observed after three days of
treatment. In contrast, 7S DNA is stabilized in the absence of
MGME1 and can still be observed after 3 days of ddC treatment
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Fig. 4 Mgme1−/− mice progressively accumulate COX negative cells in heart and colon tissue. COX/SDH staining of heart (a–c); colon (d–f); and skeletal
muscle (g–i) from 45 and 70-week-old mice. White arrows indicate COX-defective cells. Scale bar, 100 µm. Three biological replicates per genotype
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(Fig. 5d, lane 4 vs lane 2). To elucidate whether the increased
stability of 7S DNA was associated with structural changes, we
defined the 3′ and 5′ ends of 7S DNA in Mgme1−/−mice
(Supplementary Fig. 5a, b). Ligation-mediated (LM)-PCR analysis
showed a tendency of shift towards longer 5′ DNA ends in the
absence of MGME1 (Supplementary Fig. 5a, b). In contrast, LM-
PCR analyses as well as 3′ polyadenylation-mediated PCR
amplification revealed only modest changes in the 3′ ends of 7S
DNA of Mgme1−/−mice (Supplementary Fig. 5a). Extended 5′
ends of 7S DNA have also been reported in fibroblasts from
patients with MGME1 mutations and it has been speculated that
this may explain the increased stability of 7S DNA23.
MGME1 interacts with mtDNA replication factors. To further
establish a role for MGME1 in mtDNA replication we performed a
search for interacting partners by using a proximity-biotinylation
assay (BioID)36 followed by affinity purification and mass spec-
trometry. The expression of human MGME1-BirA* in cultured
human cells leads to an increase of protein biotinylation (Supple-
mentary Fig. 6a) and the BirA tag does not interfere with the
mitochondrial localization of the fusion protein (Supplementary
Fig. 6b). Our results confirm that MGME1 interacts with the cat-
alytic subunit of the mtDNA polymerase (POLGA) (Fig. 6)23,37.
Furthermore, we identified a number of other mitochondrial
replication-related proteins that could be interactors of MGME1,
e.g., mitochondrial single-stranded DNA-binding protein (SSBP1),
mitochondrial RNA polymerase (POLRMT) and TWINKLE (Fig. 6,
Supplementary Data 1). As expected, several naturally biotinylated
mitochondrial proteins, such as pyruvate carboxylase (PC),
propionyl-CoA carboxylase (PCC), and methylcrotonyl-CoA car-
boxylase (MCCC1) were also identified in the affinity purification
experiments. In addition, we identified very abundant mitochon-
drial proteins, such as proteases and respiratory chain subunits,
which likely represent contaminants as we often find these proteins
in various types of protein interaction studies.
Lack of MGME1 influences mitochondrial transcription. Next,
we investigated the steady-state levels of mitochondrial rRNAs,
tRNAs, and mRNAs in heart tissue from Mgme1−/− mice.
Unexpectedly, there was a decrease in the abundance of
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mitochondrial transcripts from HSP and an increase of
promoter–proximal transcripts from LSP in Mgme1−/− mice
(Fig. 7a, b, Supplementary Fig. 7a). Promoter-distal LSP tran-
scripts, such as tRNAAsn and tRNACys, did not change sig-
nificantly in Mgme1−/− mice. Normally, there is frequent
termination of LSP transcription at CSB1 to generate the abun-
dant polyadenylated 7S RNA (Fig. 7c) with a poorly understood
function38. The steady-state levels of 7S RNA were markedly
decreased in Mgme1−/− mice (Fig. 7c, Supplementary Fig. 7b). In
contrast, we found markedly increased levels of an antisense H-
strand transcript that spans over the control region, the so called
anti control region transcript (ACR) (Fig. 7d). This transcript,
which has an opposite sense to LSP transcripts, has previously
been reported to increase in abundance in response to decreased
mtDNA transcription initiation, decreased mtDNA replication or
inhibition of mitochondrial translation38–40,41. This finding is in
nice agreement with previous results showing that in the absence
of premature termination of mtDNA replication (leading to
decreased de novo formation of 7S DNA) the levels of the ACR
transcript are increased38,41.
Loss of MGME1 does not affect mitochondrial protein levels.
As loss of MGME1 leads to decreased levels of full-length
mtDNA and the formation of high levels of a linear subgenomic
mtDNA molecule (Fig. 2), we decided to investigate the steady-
state levels of mitochondrial proteins encoded by mtDNA and
nuclear genes (Fig. 8). The steady-state levels of (OXPHOS)
subunits were normal in mitochondrial protein extracts (Fig. 8a,
b) and the organization of the respiratory complexes was unal-
tered on blue native polyacrylamide gel electrophoresis (BN-
PAGE) of mitochondrial extracts from Mgme1−/− mice (Fig. 8c).
We also found normal levels of proteins involved in mtDNA
replication, transcription, and RNA maturation, such as mito-
chondrial transcription termination factor 1 (MTERF1)42,43,
leucine-rich pentatricopeptide repeat-containing (LRPPRC),
mitochondrial transcription factor A (TFAM)44,45, POLRMT46,
and TWINKLE34 (Fig. 8a, b). Despite accumulation of linear
subgenomic mtDNA, depletion of mtDNA and replication stal-
ling in young animals, there were no clear OXPHOS defects. This
is probably due to compensatory mechanisms acting on various
levels of the mtDNA expression axis thus resulting in high
threshold levels, i.e., the overall mtDNA expression must be
substantially reduced before respiratory chain deficiency occurs.
Tissue-specific replication stalling in Mgme1 knockout mice.
To gain a more detailed insight into the integrity of mtDNA we
performed next generation sequencing of mtDNA from liver
(Fig. 9a), heart (Fig. 9d) and brain (Supplementary Fig. 8) of
Mgme1−/− mice. The relative sequence coverage pattern of
mtDNA from the liver of Mgme1−/− mice (Fig. 9a) was very
similar to the previously published pattern in liver from PolgAmut/
mut mice25,26 and is consistent with the presence of a linear
subgenomic mtDNA fragment extending from OH to OL in both
Mgme1−/− (Fig. 2d, Supplementary Fig. 2d) and PolgAmut/mut
mice25. Further analysis of mtDNA by neutral-neutral two-
dimensional agarose gel electrophoresis (2DNAGE) showed a
prominent and site-specific stalling of mtDNA replication in
the region of OL (Fig. 9c) consistent with the sharp decline in
sequence coverage after this point. In striking contrast, the
sequence coverage pattern of mtDNA from heart (Fig. 9d) and
brain (Supplementary Fig. 8a) of Mgme1−/− mice showed more
of a gradual decrease with the most abundant sequences being
present close to OH. 2DNAGE analysis of heart and brain
mtDNA from Mgme1−/− mice showed a generalized increase in
the abundance of replication intermediates at all points along
the replication fork arc (Fig. 9e, f; Supplementary Fig. 8b, c;
Supplementary Fig. 9). This is consistent with a non-specific
replication stalling phenotype as documented by the decreased
sequence coverage as the distance from the origin of replication
increases.
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Disscussion
In this study, we report that the loss of MGME1 has marked
effects on mtDNA replication in vivo. The Mgme1−/− mice are
viable but exhibit an mtDNA replication stalling phenotype that
surprisingly shows a tissue-specific pattern and is associated with
decreased mtDNA copy number and an accumulation of mtDNA
deletions. Furthermore, we report an unexpected role for
MGME1 in the regulation of mtDNA replication and transcrip-
tion termination at the end of the D-loop region. Proximity
labeling experiments with the Bio-ID method showed that
MGME1 interacts with a number of components of the replica-
tion machinery. MGME1, thus, has an important role in the
regulation of mtDNA replication.
Loss of MGME1 in mice causes an increase in the steady-state
levels of 7S DNA, consistent with the previously suggested role of
MGME1 in degrading this mtDNA species7,23. Importantly, de
novo replication of mtDNA occurs in the absence of MGME1,
but the formation of 7S DNA is severely decreased. This striking
discrepancy between impaired de novo synthesis and increased
steady-state levels of 7S DNA is likely explained by increased
stability of these molecules in the absence of MGME1 activity. It
has been estimated that the 7S DNA in patient fibroblasts has a
four-fold longer half-life than in control cells23, and here we
report increased stability of the 7S DNA species in Mgme1−/−
MEFs after mtDNA replication inhibition with the chain-
terminating nucleotide analog ddC. Interestingly, the severely
decreased de novo formation of 7S DNA argues that MGME1
may also modulate replication termination at the end of the D-
loop region. Support for a regulatory role for MGME1 at the end
of the D-loop region comes from the observation that tran-
scription from HSP, which is normally terminated at this region,
is aberrantly regulated in the absence of MGME1. Lack of HSP
transcription termination results in accumulation of an ACR
transcript over the D-loop region. This ACR transcript has also
been described to form in response to thiamphenicol or ddC
treatment of tissue culture cells38,40. We have previously reported
in vivo evidence for ACR transcript accumulation in transgenic
mice with impaired mtDNA transcription initiation41. In this
mouse strain, knockout of Tfam in heart, which typically results
in severe cardiomyopathy, was rescued by expression of the
human TFAM gene. Interestingly, in addition to ACR transcript
accumulation in those rescue mice the levels of 7S DNA were
significantly reduced. We propose that MGME1 might be part of
regulatory switch acting at the end of the D-loop region that
controls mtDNA replication and H-strand transcription termi-
nation. Similarly, we have recently shown that the mitochondrial
transcription termination factor 1 (MTERF1) blocks transcription
initiated from LSP, just downstream of the ribosomal transcrip-
tion unit, preventing formation of an antisense transcript over the
D-loop region and interference with the activity of the LSP
promoter in the mouse42. Moreover, MTERF1 was recently
suggested to display contrahelicase activity and would therefore
be able to counteract DNA unwinding by the TWINKLE helicase,
which is a termination mechanism that may prevent the
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replication and transcription machineries from colliding43.
Interestingly, ChIP sequencing experiments recently demon-
strated that TWINKLE may also be important for the regulation
of replication at the 3′ end of 7S DNA in the control region38.
Importantly, the Bio-ID experiments we present here show an
interaction between MGME1 and TWINKLE. The prevention of
interference between the mitochondrial replication and tran-
scription machineries, as well as prevention of promoter inter-
ference seems to require complex regulation on multiple levels.
In line with the above-discussed results, Mgme1−/− mice dis-
play reduced steady-state levels of the transcript originating from
the HSP promoter, whereas promoter–proximal transcripts from
LSP are increased and promoter-distal transcripts unaltered. It is
likely that the ACR transcript, if abundant, interferes with the
HSP promoter leading to a decrease of HSP transcription
initiation. As a consequence, the transcription apparatus would
shift to the LSP promoter thus resulting in an increased tran-
scription initiation from LSP and higher levels of LSP
promoter–proximal transcripts. Interestingly, despite boosted
proximal transcription from LSP, the 7S RNA levels were
decreased in Mgme1−/− mice. The function of this promoter
proximal transcript is unknown, but it is often discussed in the
context of replication primer formation38,47. We propose that
most LSP initiation events are used for DNA synthesis in our
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experimental model, thereby leading to the absence of 7S RNA.
In agreement with this model, we report increased sequence
coverage reads consistent with a replication initiation boost at
OH and an increase of promoter-proximal LSP transcripts in
Mgme1−/− mice.
Lack of MGME1 causes mtDNA depletion and accumulation
of mtDNA deletions in a range of different mouse tissues. A
hallmark of MGME1 deficiency in patient fibroblasts and mice is
an 11 kb linear mtDNA fragment spanning the entire major arc of
the mtDNA, which has been previously described in mtDNA
mutator mice25 and flies48. According to a recently suggested
model, the 11 kb linear abnormal replication products arise from
failed ligation of the nascent H-strand at OH and are a con-
sequence of non-ligatable flaps created at the origin of replica-
tion27,49. Numerous studies suggest that mtDNA mutations and
deletions contribute to the ageing phenotypes in experimental
animals and in humans13,50–52. Indeed, mtDNA mutator mice
develop progressive premature ageing syndrome phenotypes25,53.
In addition to the presence of the above mentioned 11 kb sub-
genomic mtDNA species, the mtDNA mutator mice also accu-
mulate an increased number of point mutations, that most likely
drive the ageing phenotype54. Consistent with this hypothesis,
Mgme1−/− mice do not accumulate point mutations and do not
display a progeroid phenotype. In line with this finding, mtDNA
subgenomic fragments have not been detected in tissues from
aging mammals further indicating that this lesion on its own does
not induce ageing51.
Both 2DNAGE and sequence analysis of mtDNA isolated from
various Mgme1−/− tissues revealed remarkable tissue-specific
molecular phenotypes. The 2DNAGE analysis of Mgme1−/− heart
and brain showed a general and unspecific accumulation of repli-
cation intermediates along the replication arc, suggesting that
replication is stalling along the entire restriction fragment. Similarly,
downregulation of MGME1 in tissue culture cells induces a com-
parable non-specific stalling effect7. This result was different to what
was seen in liver tissue of the Mgme1−/− mice, where a very pro-
minent stalling site was observed in the vicinity of OL. Furthermore,
deep sequencing of liver mtDNA from Mgme1−/− mice showed a
sequence coverage plot that reflects the presence of linear fragments
with a large deletion. A similar sequence coverage has been pre-
viously reported from liver samples of mtDNA mutator mice26. The
coverage profiles of Mgme1−/− samples from brain and heart dis-
played a different pattern including a pronounced peak of 7S DNA
sequence and loss of sequence coverage in the direction of repli-
cation. These differences between the liver on the one hand and
heart tissue on the other hand are in agreement with the distinct
replication stalling profiles revealed by 2DNAGE data from these
tissues. The increased reads along the major arc in the liver indicate
that replication has trouble passing OL, predominantly replicating
the major arc, explaining the specific stalling in the 2DNAGE. The
unusual slope in sequence coverage from the heart suggests that
replication is initiated faster than it can be completed, resulting in
more reads closer to the origin and generalized stalling as seen on
the 2D gel experiments.
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The observed tissue specificity of our Mgme1−/− mouse model
is in accord with the well-known tissue heterogeneity of mito-
chondrial disorders55. The tissue-specific phenotypes may, at least
partly, be explained by the observation that diverse tissues have
different energy demands and biosynthetic capacities. The
synthesis of mtDNA relies tightly on a balanced dNTP pool,
which depends on the mitochondrial dNTP salvage pathways and
assisted transport of cytosolic dNTPs to mitochondrial matrix56.
These processes are likely differentially regulated in various tis-
sues, thereby contributing to the tissue-specific manifestations of
mitochondrial mtDNA maintenance diseases as exemplified by
patients carrying mutations in enzymes important for the mito-
chondrial nucleotide salvage pathways, e.g., TK210 and MPV1757.
In conclusion, we show here that MGME1 is a replication-
related nuclease, necessary for 5′ 7S DNA processing and faithful
mtDNA replication in mice. Absence of MGME1 results in tissue-
specific replication stalling and accumulation of deleted mtDNA
molecules but does not create a progeroid phenotype in affected
animals. We propose that MGME1 is part of a termination
complex acting at the end of the D-loop region where it mod-
ulates mtDNA replication and H-strand transcription termina-
tion. The tissue-specific molecular phenotypes associated with
MGME1 deficiency suggest that the Mgme1−/− mice will be a
valuable model for investigation of the pathophysiology of
mtDNA maintenance disorders.
Methods
Animals and housing. Knockout transgenic mice on a C57BL/6N background
were housed in standard individually ventilated cages (45 × 29 × 12 cm) under a 12
h light/ dark schedule in controlled environmental conditions of 22 ± 2 °C and 50
+ 10% relative humidity and fed a normal chow diet and water ad libitum. The
study was approved by the Landesamt für Natur, Umwelt und Verbraucherschutz
Nordrhein–Westfalen (reference numbers 84-02.04.2015.A103 and
84-02.50.15.004) and performed in accordance with the recommendations and
guidelines of the Federation of European Laboratory Animal Science Associations
(FELASA).
Generation of Mgme1 knockout mice. The targeting vector for disruption of
Mgme1 in embryonic stem cells has been generated using BAC clones from the
C57BL/6J RPCIB-731 BAC library and has been transfected into the Taconic
Artemis C57BL/6N Tac ES cell line. To generate conditional knockout Mgme1
mice, exon III was flanked by loxP sites. The puromycin resistance cassette was
introduced as a selection marker and removed by mating of Mgme1+/loxP-pur mice
with transgenic mice ubiquitously expressing Flp-recombinase. Mgme1+/loxP mice
were mated with mice ubiquitously expressing cre-recombinase (β-actin-cre) to
generate heterozygous knockout Mgme1+/− mice. Mgme1+/− mice were further
intercrossed to generate homozygous knockout Mgme1+/− mice. To obtain tissue-
specific (heart and skeletal muscle) knockout mice34 Mgme1loxP/loxP mice were
crossed with transgenic mice expressing cre-recombinase under the control of the
muscle creatinine kinase promoter (Ckmm-cre).
Isolation of mitochondria from mouse tissue. Mitochondria were isolated from
mouse tissues using differential centrifugation as previously described34. Briefly,
fresh tissues were cut, washed with ice cold PBS and homogenized in mitochon-
drial isolation buffer (MIB) containing 310 mM sucrose, 10 mM Tris-HCl, and 1
mM EDTA by using a Potter S pestle (Sartorius). The homogenate was centrifuged
at 1000× g for 10 min at 4 °C and the supernatant was subsequently spun at
10,000× g for 15 min at 4 °C to isolate mitochondria. Crude mitochondrial pellets
were suspended in MIB supplemented with 1 × Complete protease inhibitor
cocktail (Roche). Protein concentration was determined by the Bradford method
using BSA as a standard. Mitochondria from brain tissue were isolated following
protocol from Miltenyi Biotec mitochondrial extraction tissue kit using TOM22
MicroBeads.
DNA extraction and Southern blot analysis. Genomic DNA was isolated by
Gentra Puregene Tissue Kit (Qiagen) according to kit instuctions. DNA quantifi-
cation was performed with the Qubit 1.0 fluorometer (Thermofisher). A volume of
2 μg of DNA were digested with SacI, XhoI, SphI, or EagI and DNA fragments were
separated by agarose gel electrophoresis, transferred to nitrocellulose membranes
(Hybond-N+membranes, GE Healthcare) and hybridization was carried out with
α32P-dCTP-labeled probes. For 7S DNA Southern samples were heated for 3 min at
93 °C prior to loading. List of probes can be find in Supplementary Data 2.
Uncropped scans of important Southern blots with marker lanes are presented in
Supplementary Fig. 10.
In organello replication. A volume of 1 mg of freshly isolated heart mitochondria
was resuspended in 0.5 ml of incubation buffer (25 mM sucrose, 75 mM sorbitol,
100 mM KCl, 10 mM K2HPO4, 0.05 mM EDTA, 5 mM MgCl2, 1 mM ADP, 10 mM
glutamate, 2.5 mM malate, 10 mM Tris–HCl, pH 7.4) supplemented with 1 mg/ml
fatty acid-free bovine serum albumin, 50 µM each of dTTP, dCTP, and dGTP and
20 µCi α-32P-dATP (3000 Ci/mmol). Incubation was carried out at 37 °C for 2 h on
a rotating wheel. Chase experiments were followed by incubation with non-
radiolabeled dATP (5 mM) for additional hour. After incubation, mitochondria
were pelleted at 9000 rpm for 4 min and washed twice with 10% glycerol, 10 mM
Tris–HCl, pH 6.8, 0.15 mM MgCl2. In the following step DNA isolation and
Southern blot analysis were performed as described above.
Long-extension PCR. Mouse mtDNA was amplified from 2 ng of total DNA with
the following primers (P1:488-510, P2:4021-4040) using LA Taq polymerase
(TAKARA, Japan) and following PCR conditions: 98 °C for 10 s, 58 °C for 30 s, and
60 °C for 10 min, 35 cycles.
Northern blot analysis. Northern blot transcript analysis was performed as pre-
viously described34. Briefly, RNA, 2 μg, was isolated using the ToTALLY RNA
Total RNA isolation kit (Ambion), separated in formaldehyde agarose gels and
transferred to Hybond-N+membranes (GE Healthcare) by northern blotting.
DNA probes, α-32P-dCTP-labeled, were used for visualization of mRNA and rRNA
levels. Different tRNAs and 7S RNA were detected using specific oligonucleotides
labeled with γ-32P-ATP. For the detection of the ACR transcript riboprobe was
synthetized using Riboprobe System T7 Kit (Promega). List of probes can be find in
Supplementary Data 2.
Western blot analysis and BN-PAGE. A volume of 20 μg of isolated mitochondria
were resuspended in 4 × Lämmli-Buffer (4% SDS, 20% Glycerol, 120 mM Tris,
0,02% Bromophenol Blue), proteins were separated on 4–12% NuPage gels
(Invitrogen) and transferred on HybondTM-P membrane (GE Helthcare). Primary
antibodies used for western blotting were as follows: MitoProfile total OXPHOS
antibody cocktail (MitoSciences), HSP60 (Cell signalling, 1:1000), COX1 (Invi-
trogen, 1:1000), MTERF1 (Proteintech, 1:1000), TFAM (Abonva, 1:1000), SDH2
(MitoScience). Rabbit polyclonal antisera against MGME1, TWINKLE, POLRMT,
COX2, LRPPRC proteins were generated using recombinant mouse proteins.
For BN-PAGE 75 µg mitochondria were solubilized in solubilization buffer: 1%
(w/v) digitonin (Calbiochem), 20 mM Tris, pH 7.4, 0.1 mM EDTA, 50 mM NaCl,
10% (v/v) glycerol. Following 15 min of incubation on ice, non-solubilized material
was removed by centrifugation and the supernatant was mixed with loading dye
(5% (w/v) Coomassie Brilliant Blue G-250 (Serva), 100 mM Tris, pH 7, 500 mM 6-
aminocaproic acid). Samples were resolved on 3–13% (w/v) acrylamide gradient
BN-PAGE gels. BN gels were further subjected to Coomassie Brilliant Blue R
staining, in-gel activity assay58 or western blot analysis, as indicated.
Library preparation and Illumina pair-end DNA sequencing. Pair-end sequen-
cing was performed by the Max Planck-Genome-centre Cologne, Germany (http://
mpgc.mpipz.mpg.de/home/). mtDNA Quality control was done using the Agilent
TapeStation Genomic DNA ScreenTape and the Qubit BR kit. The library pre-
paration protocol/kit was the NEBNext Ultra™ DNA Library Prep Kit for Illumina
(NEB) after fragmentation of 150 ng gDNA with the Covaris sonicator to the
requested insert size of >500 bp. The sequencing run conditions were 2 × 250 bp on
the Illumina HiSeq2500, using HiSeq Rapid v2 Kits from Illumina. Each library was
indexed individually with the provided barcodes and sequenced to 6,000,000 reads
(tolerance range −30%) The reads were aligned to the C57Bl/6 J mouse mtDNA
reference sequence (NC_005089.1), using the corona lite mapping algorithm
(Applied Biosystems) with default settings. The first 49 bases of the mtDNA
sequence were appended to the end of the reference to avoid that reads fail to align
due to the circularity of the mitochondrial genome. This alignment procedure
attempts to map each read at full-length to the reference sequence, allowing for at
most 6 mismatches for each 50 bp read.
2DNAGE. For two-dimensional gels, mtDNA was isolated from fresh sucrose
gradient purified mitochondria from liver and heart tissues and the by sequential
phenol-chloroform extraction. The resulting DNA (3 μg per panel) was digested
with BclI, precipitated and loaded onto 0.4% agarose without ethidium bromide.
First dimension gels were separated at 27 V for 18 h at room temperature, then
DNA-containing lanes were excised with a scalpel, rotated 90° counterclockwise,
and molten 1% agarose containing 500 ng/ml ethidium bromide was cast around
the gel slices. Second-dimension gels were run at a constant 260 mA for 6 h at 4 °C.
Gels were Southern blotted onto nylon membranes and hybridized with probes
detecting either the OH-containing fragment or the OL-containing fragment. Pri-
mer sequences used for probe synthesis (5′-3′) were: OH forward,
ATCAATGGTTCAGGTCATAAAATAATCATCAAC; OH reverse,
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GCCTTAGGTGATTGGGTTTTGC; OL forward, TGACTTGTCCCACTAA-
TAATCGGAG; and OL reverse, CCCAAAGAATCAGAACAGATGCTG.
ddC treatment of mouse embryonic fibroblasts. 2,3′ Dideoxycytidine (Sigma)
was used at a final concentration of 20 µM. Cells were treated for 3 days and
afterwards resuspended in fresh medium at a concentration of 1.5–2 × 105 cells/ml.
Total DNA was isolated by Gentra Puregene Tissue Kit and extraction was per-
formed as instructed in the kit.
Bio-ID. MGME1-BirA*-HA and MTS-BirA*-HA (MTS from human COX8a) and
were cloned into pcDNA3.1 MCS-BirA (R118G)-HA vector (Addgene, Cambridge,
MA, USA). Pull-down experiments were performed according to the published
protocol36 with small modifications. HeLa cells were transfected using Lipofectamine
2000 (Invitrogen), treated with 50 µM biotin 24 h after transfection and lysed after 6 h
in 2.4ml lysis buffer (50mM Tris-Cl, pH 7.4, 500mM NaCl, 0.2% SDS, 1 × protease
inhibitor (Halt Protease Inhibitor Cocktail, EDTA-free, Thermo Fisher Scientific), 1
mM DTT. Subsequently, 240 µl of 20% Triton-X 100 (final concentration2%) was
added. After sonication samples were centrifuged at 16,500× g, 4 °C for 10min.
Dynabeads MyOne Streptavidin C1 (Thermo Fisher Scientific) were incubated with
the lysates on a rotator at 4 °C over night. Following washing in 1.5ml wash buffer 2
(0.1% (w/v) deoxycholic acid, 1% (w/v) TritonX-100, 1mM EDTA, 500mM NaCl,
50mM HEPES, pH 7,5) five successive washing steps with 1,5ml 50mM Tris-Cl, pH
7.4, were applied. Samples were eluted in elution buffer (2M Urea, 5 ng/µl Trypsin, 1
mM TCEP, 50mM Tris-Cl, pH 7.5) at room temperature. A volume of 5 mM CAA
was added to the samples and reaction was incubated at 37 °C over night. The samples
were further analyzed by LC MS/MS mass spectrometry. The mass spectrometry
proteomics data have been deposited to the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identifier PXD009138.
COX/SDH double-labeling enzyme histochemistry. COX/SDH double staining
was performed as previously described29. Briefly, fresh heart and skeletal muscle
tissues were dissected and immediately frozen in isopentane chilled with liquid
nitrogen. Colon tissue was upon dissection frozen with liquid nitrogen. Tissues
were further cryosectioned into sections (10 μm for skeletal muscle and colon; 7 μm
for heart), mounted on slides and left to air dry briefly. Freshly prepared buffer A
(0.8 ml of 5 mM 3,3′-diaminobenzidine tetrahydrochloride, 0.2 ml of 500 μM
cytochrome c and 10 μl of catalase) was added to the slides. After incubation for 60
minutes at 37 °C, slides were washed three times by 0.1 M phosphate buffered
saline, pH 7.0. Then freshly prepared buffer B (0.8 ml 1.875 mM of nitroblue
tetrazolium, 0.1 ml 1.3 M of sodium succinate, 0.1 ml 2.0 mM phenazine metho-
sulphate, and 10 μl of 100 mM sodium azide) was applied and incubated for 30
minutes at 37 °C. Slides were washed three times with 0.1 M phosphate buffered
saline, pH 7.0, dehydrated and mounted for bright-field microscopy.
Sperm motility analysis. Sperm motility analysis was performed using Computer-
assisted semen analysis (CASA) as previously described29. Briefly, the cauda region
of the right epididymis of each mouse was clamped proximally and distally, excised
and rinsed briefly in pre-warmed PBS, and placed in a 1.5 ml Eppendorf tube
containing fresh, pre-warmed M2 medium (SIGMA). The cauda epididymis was
then unclamped and pierced with the point of a scalpel blade to allow sperm to
diffuse into the medium. Sperm were allowed to disperse for 10 min at 37 °C and
were then appropriately diluted with fresh medium to permit sperm motility
analysis of 10 μL sperm suspension by CASA detection (Hamilton Thorne
Research Inc. Beverly, MA, USA).
Data availability. All the data needed to evaluate the conclusions in the paper are
present in the paper and/or the Supplementary Information. The Illumina
sequencing data is data freely available in the NCBI Sequence Read Archive under
the Study ID SRP132950 under Accession Numbers SRX3712521—SRX3712536
(https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP132950)[http://www.ncbi.
nlm.nih.gov/bioproject/434306]. The additional data related to this paper may be
requested from the authors.
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